A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis
Public ClinicalTrials.gov record NCT01096862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Randomized, Double-blind, Placebo-Controlled, Sequential Group, Multiple-Dose Escalation Study to Evaluate the Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to explore the efficacy and safety of multiple, escalating doses of ASP015K when compared to placebo in subjects with moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT01096862
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 22, 2010
- Primary completion
- Jul 26, 2011
- Completion
- Jul 26, 2011
- Last update posted
- Oct 20, 2024
2010 – 2011
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin & Beauty Dermatology Center | Birmingham | Alabama | 35205 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| FXM Research, Corp. | Miami | Florida | 33175 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Derm Research, PLLC | Louisville | Kentucky | 40217 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Palmetto Clinical Trial Services | Greenville | South Carolina | 29607 | — |
| Rivergate Dermatology | Goodlettsville | Tennessee | 37072 | — |
| J & S Studies | College Station | Texas | 77845 | — |
| Virginia Clinical Research | Norfolk | Virginia | 23507 | — |
| Madison Skin & Research, Inc | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01096862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2024 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01096862 live on ClinicalTrials.gov.